ArticleBritish journal of cancer2020

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.

Ashleigh M Fordham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.